deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01967862

Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer

F18 NaF PET/CT and Whole Body and Axial MRI for the Detection of Metastases in Patients With Biochemical Recurrence of Prostate Cancer

Sponsor: City of Hope Medical Center

Conditions Recurrent Prostate Cancer
Interventions 3-Tesla magnetic resonance imaging bone scan computed tomography diffusion-weighted magnetic resonance imaging fluorine F 18 sodium fluoride laboratory biomarker analysis positron emission tomography
Updated 13 times since 2017 Last updated: Aug 26, 2020 Started: Dec 31, 2013 Primary completion: Sep 17, 2018 Completion: Sep 17, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Recurrent Prostate Cancer and is currently completed. City of Hope Medical Center leads this study, which shows 13 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Sep 2017 · 6 months · monthly snapshot~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Sep 2020 · 23 months · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  5. Jan 2021 — Dec 2022 [monthly]

    Completed NA

▶ Show 8 earlier versions

  1. Oct 2020 — Jan 2021 [monthly]

    Completed NA

    Phase: PHASE2 → NA

  2. Sep 2020 — Oct 2020 [monthly]

    Completed PHASE2

  3. Oct 2018 — Sep 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jun 2018 — Oct 2018 [monthly]

    Active Not Recruiting PHASE2

  5. Sep 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  6. Mar 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE2

  7. Feb 2017 — Mar 2017 [monthly]

    Active Not Recruiting PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • City of Hope Medical Center
  • National Cancer Institute (NCI)
Data source: City of Hope Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations